vs

Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and Mid-America Apartment Communities (MAA). Click either name above to swap in a different company.

Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $553.7M, roughly 1.7× Mid-America Apartment Communities). On growth, Mid-America Apartment Communities posted the faster year-over-year revenue change (438.7% vs 42.9%). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 0.7%).

Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.

Mid-America Apartment Communities, Inc. (MAA) is a publicly traded real estate investment trust based in Memphis, Tennessee that invests in apartments in the Southeastern United States and the Southwestern United States.

ASTH vs MAA — Head-to-Head

Bigger by revenue
ASTH
ASTH
1.7× larger
ASTH
$950.5M
$553.7M
MAA
Growing faster (revenue YoY)
MAA
MAA
+395.8% gap
MAA
438.7%
42.9%
ASTH
Faster 2-yr revenue CAGR
ASTH
ASTH
Annualised
ASTH
53.3%
0.7%
MAA

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ASTH
ASTH
MAA
MAA
Revenue
$950.5M
$553.7M
Net Profit
$6.6M
Gross Margin
Operating Margin
1.9%
Net Margin
0.7%
Revenue YoY
42.9%
438.7%
Net Profit YoY
184.4%
EPS (diluted)
$0.12
$4.34

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASTH
ASTH
MAA
MAA
Q1 26
$553.7M
Q4 25
$950.5M
$555.6M
Q3 25
$956.0M
$554.4M
Q2 25
$654.8M
$549.9M
Q1 25
$620.4M
$549.3M
Q4 24
$665.2M
$549.8M
Q3 24
$478.7M
$551.1M
Q2 24
$486.3M
$546.4M
Net Profit
ASTH
ASTH
MAA
MAA
Q1 26
Q4 25
$6.6M
$57.6M
Q3 25
$373.0K
$99.5M
Q2 25
$9.4M
$108.1M
Q1 25
$6.7M
$181.7M
Q4 24
$-7.8M
$166.6M
Q3 24
$16.1M
$115.2M
Q2 24
$19.2M
$102.0M
Operating Margin
ASTH
ASTH
MAA
MAA
Q1 26
Q4 25
1.9%
10.4%
Q3 25
2.0%
18.7%
Q2 25
3.1%
20.2%
Q1 25
3.3%
34.0%
Q4 24
0.1%
31.3%
Q3 24
5.9%
21.5%
Q2 24
6.2%
19.3%
Net Margin
ASTH
ASTH
MAA
MAA
Q1 26
Q4 25
0.7%
10.4%
Q3 25
0.0%
18.0%
Q2 25
1.4%
19.7%
Q1 25
1.1%
33.1%
Q4 24
-1.2%
30.3%
Q3 24
3.4%
20.9%
Q2 24
3.9%
18.7%
EPS (diluted)
ASTH
ASTH
MAA
MAA
Q1 26
$4.34
Q4 25
$0.12
$0.48
Q3 25
$0.01
$0.84
Q2 25
$0.19
$0.92
Q1 25
$0.14
$1.54
Q4 24
$-0.14
$1.43
Q3 24
$0.33
$0.98
Q2 24
$0.40
$0.86

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASTH
ASTH
MAA
MAA
Cash + ST InvestmentsLiquidity on hand
$429.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$779.3M
Total Assets
$2.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASTH
ASTH
MAA
MAA
Q1 26
Q4 25
$429.5M
$60.3M
Q3 25
$463.4M
$32.2M
Q2 25
$342.1M
$54.5M
Q1 25
$260.9M
$55.8M
Q4 24
$290.8M
$43.0M
Q3 24
$350.3M
$50.2M
Q2 24
$327.7M
$62.8M
Stockholders' Equity
ASTH
ASTH
MAA
MAA
Q1 26
Q4 25
$779.3M
$5.7B
Q3 25
$775.5M
$5.8B
Q2 25
$765.5M
$5.9B
Q1 25
$745.4M
$5.9B
Q4 24
$712.7M
$5.9B
Q3 24
$704.6M
$5.9B
Q2 24
$678.9M
$6.0B
Total Assets
ASTH
ASTH
MAA
MAA
Q1 26
Q4 25
$2.2B
$12.0B
Q3 25
$2.2B
$11.9B
Q2 25
$1.4B
$11.8B
Q1 25
$1.3B
$11.8B
Q4 24
$1.4B
$11.8B
Q3 24
$1.3B
$11.8B
Q2 24
$1.3B
$11.6B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASTH
ASTH
MAA
MAA
Operating Cash FlowLast quarter
$-2.9M
Free Cash FlowOCF − Capex
$-6.0M
FCF MarginFCF / Revenue
-0.6%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
-0.44×
TTM Free Cash FlowTrailing 4 quarters
$104.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASTH
ASTH
MAA
MAA
Q1 26
Q4 25
$-2.9M
$261.7M
Q3 25
$10.0M
$266.4M
Q2 25
$90.9M
$353.4M
Q1 25
$16.6M
$196.6M
Q4 24
$-10.9M
$239.1M
Q3 24
$34.0M
$309.5M
Q2 24
$23.2M
$349.4M
Free Cash Flow
ASTH
ASTH
MAA
MAA
Q1 26
Q4 25
$-6.0M
$158.6M
Q3 25
$7.4M
$170.8M
Q2 25
$89.5M
$264.5M
Q1 25
$13.6M
$124.0M
Q4 24
$-13.5M
$152.6M
Q3 24
$31.7M
$215.5M
Q2 24
$20.4M
$259.7M
FCF Margin
ASTH
ASTH
MAA
MAA
Q1 26
Q4 25
-0.6%
28.5%
Q3 25
0.8%
30.8%
Q2 25
13.7%
48.1%
Q1 25
2.2%
22.6%
Q4 24
-2.0%
27.8%
Q3 24
6.6%
39.1%
Q2 24
4.2%
47.5%
Capex Intensity
ASTH
ASTH
MAA
MAA
Q1 26
Q4 25
0.3%
18.6%
Q3 25
0.3%
17.2%
Q2 25
0.2%
16.2%
Q1 25
0.5%
13.2%
Q4 24
0.4%
15.7%
Q3 24
0.5%
17.1%
Q2 24
0.6%
16.4%
Cash Conversion
ASTH
ASTH
MAA
MAA
Q1 26
Q4 25
-0.44×
4.55×
Q3 25
26.69×
2.68×
Q2 25
9.65×
3.27×
Q1 25
2.48×
1.08×
Q4 24
1.43×
Q3 24
2.11×
2.69×
Q2 24
1.21×
3.43×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASTH
ASTH

Medicare$542.4M57%
Commercial$99.1M10%
Care Delivery$92.1M10%
Care Enablement$78.9M8%
Other Third Parties$58.0M6%
Health Care Patient Service$39.8M4%
Health Care Other$25.5M3%
Other$12.1M1%
Management Service$10.3M1%

MAA
MAA

Same Store Communities$517.0M93%
Non-Same Store Communities$22.1M4%
Lease-up/Development Communities$7.7M1%
Commercial Property/Land$7.0M1%

Related Comparisons